GovChime
Notice ID: 0180db43bc954eb4a3ee8372c1c2c9cbSpecial Notice

PANDHA-26-P-0000 046638 Defibrinated Rabbit Blood

Archived on November 7, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
2:00 PM EDT
Posted
October 8, 2026
Notice type
Special Notice
Set-aside
No Set aside used
NAICS
325414: Biological Product (except Diagnostic) Manufacturing
Agency
Department of WarDEFENSE HEALTH AGENCY (DHA)

Notice details

Place of performance
Silver Spring, Maryland, 20910
Last updated
Nov 7, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
PANDHA-26-P-0000_046638
Notice ID
0180db43bc954eb4a3ee8372c1c2c9cb

Description

The Defense Health Agency Contracting Activity (DHACA) on behalf of the Walter Reed Army Institute of Research (WRAIR), intends to negotiate on a sole source basis in accordance with FAR 6.302 with vendor Lampire Biological Labs, Inc., 3599 Farm School Rd, Ottsville, PA 18942-1536


The contractor shall supply 48 units (50ml per bottle equals one unit) of defibrinated rabbit blood per period of performance, base year plus four (one-year) option periods. Each unit shall have a lot number and associated product data sheet. Product shall be packaged to protect from damage during shipping, prevent leaks or spillage, comply with appropriate shipping regulations, and maintain temperature of 2-8 degrees Celsius upon arrival at destination.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (1)

  • B01. Notice of Intent to Sole Source PANDHA-26-P-0000 046638.pdf

    98 KBAdded in Special Notice version 1Posted
    Download

Lifecycle

  1. 1
    Version 1Special NoticeCurrent

    PANDHA-26-P-0000 046638 Defibrinated Rabbit Blood

    Notice 0180db43bc954eb4a3ee8372c1c2c9cb on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
THIS IS A SOURCES SOUGHT NOTICE ONLY. This notice does NOT constitute a request for quote (RFQ), request for proposal (RFP), or invitation for bid (IFB). No solicitation is currently available. This Sources Sought is issued solely for information and planning purposes to conduct market research and determine the availability and capability of qualified sources prior to determining the appropriate acquisition strategy. I. General Information - Agency/Office: Department of Veterans Affairs (VA), VA North Texas Health Care System (VANTHCS), 4500 S. Lancaster Rd. Dallas, TX. 75216 - Place of Performance: VA North Texas Health Care System, Pathology and Laboratory Medicine Service (P&LMS), Microbiology Laboratory, Dallas, Texas. - Anticipated NAICS: 325413 In-Vitro Diagnostic Substance Manufacturing - Anticipated PSC: 6550 In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets. The Government is seeking to identify responsible vendors capable of providing Blood Bank Reagents, used to perform patient manual blood typing and serum antibody detection and identification to be used in the Transfusion Medicine Unit, Pathology and Laboratory Medicine Services at VANTHCS. II. Description of Requirement Transfusion Medicine Unit, Pathology and Laboratory Medicine Services (P&LMS) at the VA North Texas Health Care System (VANTHCS), Dallas, TX is seeking blood reagents used to perform patient manual blood typing and serum antibody detection and identification testing used for cross matching blood for transfusions. The contemplated purchase includes, at a minimum: The Contractor shall provide reagent supplies as requested by VANTHCS staff to perform blood bank manual blood typing and serum antibody detection and identification testing used for cross matching blood for transfusions. Estimated Yearly Requirements: Item # Description/Part Number* Qty Unit 1 Z401U, ALBAcyte A1 Cells 52 EA 2 Z406U, ALBAcyte A2 Cells 13 EA 3 Z411U, ALBAcyte B Cells 52 EA 4 Z4411U-1, ALBAcyte IgG Sensitized Cells (weak) 26 EA 5 Z473U, ALBAcyte Antibody ID Panel (16-cell) 7 EA 6 Z482U, ALBAcyte C3 Coated Red Blood Cells 13 EA Period of Performance: Base Year: 05/01/2027-04/30/2028 Option Year 1: 05/01/2028-04/30/2029 Option Year 2: 05/01/2029-04/30/2030 Option Year 3: 05/01/2030-04/30/2031 Option Year 4: 05/01/2031-04/30/2032 Location: The manual testing will be performed in Transfusion Medicine Unit, Pathology & Laboratory Medicine Service, VA North Texas Health Care System, 4500 S. Lancaster Rd., Dallas, TX 75216. III. Performance requirements: Performance Requirements: The following are required: Packing and Delivery: All Shipping/Freight Charges will be FOB Destination unless noted otherwise by vendor and communicated to the contracting officer prior to award. The reagents shall be delivered at the time specified when the order is placed. The Contractor will furnish appropriate containers for shipment of the reagents. Vendor must be approved by the FDA and shall provide documentation of approval. Vendor must have a defined Quality plan, and Adequate supplies available. IV. Submission Instructions Interested and capable vendors should submit an electronic capability statement and include the place of manufacture for all reagents listed in the sources sought via email in PDF or Word format by November 5, 2026, by 9:00 AM Central Standard Time. - Teresa Arzola  - Email: Teresa.arzola@va.gov  - Subject line: Sources Sought Blood Bank Reagents VA North Texas HCS  No telephone inquiries will be accepted. Responses received will be used solely for market research and planning purposes to assist the Government in determining an appropriate acquisition strategy (e.g., small business set aside or unrestricted). Submission of a capability statement is voluntary and shall not be construed as a commitment by the Government to issue a solicitation or award a contract, nor will the Government pay for information submitted in response to this Sources Sought.
66%
Market Research11/05/2026
63%
Combined Synopsis11/16/2026
NTX blood bank cost per test
62%
AwardedOpen
This is a Notice of Intent published in accordance with Federal Acquisition Regulation RFO 5.101(a) requiring the dissemination of information regarding proposed contract actions. This Notice of Intent is for a proposed award of a sole source, firm-fixed price contract under the authority of 41 U.S.C. 3304(a)(1), as implemented by RFO 6.103-1(b) - Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements. It is not a request for competitive quotes. The Department of Veterans Affairs, Network Contracting Office 23, intends to award a sole source, firm-fixed price contract to Alba Bioscience, Inc with 41 U.S.C. 3304(a)(1), as implemented by RFO 6.103-1(b) - Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements because this equipment is provided by the Original Equipment Manufacturer, Alba Bioscience, Inc. No other third-party vendor is authorized to install or service this equipment. The North American Industry Classification System (NAICS) code for this requirement is 325413, and the product service code is 6550. While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy the requirement. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The Government understands the equipment Alba Bioscience, Inc provides is proprietary. However, vendors that believe they can provide the capabilities required to fully meet the Government's requirement may submit information in writing to Robert.bennett8@va.gov within seven calendar days after publication of this notice. Such documentation will be reviewed solely for the purpose of determining whether to conduct the procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
62%
Special Notice09/30/2026
 Solicitation No: 36C26126Q0808  Posted to SAM.gov: 08/24/2026  Awardee: SIEMENS HEALTHCARE DIAGNOSTICS INC. (GC14SNHB3JN1) 511 Benedict AVE Tarrytown New York 10591-5005 United States Total Number of Quotes Received: One (1)  Evaluation Total Amount: $516,761.80  IDIQ Ceiling: $600,000.00  Period of Performance: 10/01/2026 09/30/2031
61%
AwardedOpen

Additional Details

Solicitation Number

PANDHA-26-P-0000_046638

Archive Date

Nov 7, 2026